Abstract
The article considers the issues of diagnosis and treatment of patients with newly diagnosed thrombocytosis. Based on their own clinical cases recommendations for the appointment of antiplatelet therapy to prevent thrombotic complications.
References
Schafer AI. Thrombocytosis. JAMA. 2015 Sep 15;98(4):701-5.
McMullin MF. Diagnostic workflow for hereditary erythrocytosis and thrombocytosis. Hematology. American Society of Hematology. Education Program. 2019 Dec 6;63:42-5. 102(3):41-3.
Sałacki AJ, Wysokiński A. Reactive thrombocytosis resulting from frequent blood donations as an extremely rare cause of ST Segment Elevation Myocardial Infarction in the case of a 19-year-old male. Annals of agricultural and environmental medicine. AAEM. 2018 Dec 20;93:57-4.
Rumi E, Cazzola M. Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms. Blood. 2017 Feb 9;68: 41-3.
Al-Samkari H, Kessler CM, Auerbach M. Recognition of thrombotic risk of thrombocytosis in iron deficiency. Haematologica. 2021 Mar;106(3):661-3.
Scharf RE. Do we need antiplatelet therapy in thrombocytosis? Contra. Proposal for an individualized risk-adapted treatment. Hamostaseologie. 2016 Nov 7;89:69-3.
Schattner A, Kadi J, Dubin I. Reactive thrombocytosis in acute infectious diseases: Prevalence, characteristics and timing. Eur J Intern Med. 2019 May 1;63:42-5.
Alberio L. Do we need antiplatelet therapy in thrombocytosis? Pro. Diagnostic and pathophysiologic considerations for a treatment choice. Hamostaseologie. 2016 Nov 7;109(5):397-2.
Sasaki K, Kawai K, Tsuno NH, Sunami E, Kitayama J. Impact of preoperative thrombocytosis on the survival of patients with primary colorectal cancer. World journal of surgery. 2012 Jan;87:46-8.
Moulis G, et al. Platelet counts of adults upon acute hospital admission to internal medicine units are a predictor of mortality. Ann Hematol. 2020 Mar; 99(3):451-7.